IP Verse

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al. - IPR2026-00167

Explore the PTAB proceeding IPR2026-00167 filed by Sarepta Therapeutics, Inc. et al. against Genzyme Corporation et al. on Dec 2, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2026-00167
Filing Date
Dec 2, 2025
Petitioner
Sarepta Therapeutics, Inc. et al.
Respondent
Genzyme Corporation et al.
Status
Pending
Respondent Application Number
16325653
Respondent Tech Center
1700
Respondent Patent Number
11698377

Decision Documents New

Decision pending - set alert to receive updates

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Response to Patent Owner's Discretionary Denial Brief

Mar 4, 2026PAPERPETITIONER

Ex. 1041

Mar 4, 2026EXHIBITPETITIONER

Ex. 1042

Mar 4, 2026EXHIBITPETITIONER

Ex. 1043

Mar 4, 2026EXHIBITPETITIONER

Ex. 1044

Mar 4, 2026EXHIBITPETITIONER

Ex. 1045

Mar 4, 2026EXHIBITPETITIONER

Ex. 1046

Mar 4, 2026EXHIBITPETITIONER

Ex. 1047

Mar 4, 2026EXHIBITPETITIONER

Ex. 1048

Mar 4, 2026EXHIBITPETITIONER

Ex. 1049

Mar 4, 2026EXHIBITPETITIONER

Ex. 1050

Mar 4, 2026EXHIBITPETITIONER

Ex. 1051

Mar 4, 2026EXHIBITPETITIONER

Ex. 1052

Mar 4, 2026EXHIBITPETITIONER

Ex. 1053

Mar 4, 2026EXHIBITPETITIONER

Ex. 1054

Mar 4, 2026EXHIBITPETITIONER

Ex. 1055

Mar 4, 2026EXHIBITPETITIONER

Ex. 1056

Mar 4, 2026EXHIBITPETITIONER

Patent Owner's Preliminary Response

Mar 4, 2026PAPERPATENT OWNER

Declaration of John A. McLean, Ph.D.

Mar 4, 2026EXHIBITPATENT OWNER

Curriculum Vitae of John A. McLean, Ph.D.

Mar 4, 2026EXHIBITPATENT OWNER

Wörner and Heck et al., “Adeno-associated virus capsid assembly is divergent and stochastic,”

Mar 4, 2026EXHIBITPATENT OWNER

Kontogiannis et al., “Characterization of AAV vectors: A review of analytical techniques and critical quality attributes,”

Mar 4, 2026EXHIBITPATENT OWNER

Salganik et al., “Evidence for pH-Dependent Protease Activity in the Adeno-Associated Virus Capsid,”

Mar 4, 2026EXHIBITPATENT OWNER

Supplemental Materials to Ansong et al., “Top-down proteomics reveals a unique protein S-thiolation switch in Salmonella Typhimurium in response to infection-like conditions,”

Mar 4, 2026EXHIBITPATENT OWNER

Lancaster and Ha et al., “Characterization of N-glycosylation profiles from mammalian and insect derived chikungunya VLP,”

Mar 4, 2026EXHIBITPATENT OWNER

ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2(R1)

Mar 4, 2026EXHIBITPATENT OWNER

Boys et al., “Protein Oxidative Modifications During Electrospray Ionization: Solution Phase Electrochemistry or Corona Discharge-Induced Radical Attack?,”

Mar 4, 2026EXHIBITPATENT OWNER

Knolhoff, Callahan, and Croley, “Mass Accuracy and Isotopic Abundance Measurements for HR-MS Instrumentation: Capabilities for Non-Targeted Analyses,”

Mar 4, 2026EXHIBITPATENT OWNER

Valeja et al., “Three Dimensional Liquid Chromatography Coupling IEC/HIC/RPC for Effective Protein Separation in Top-Down Proteomics,”

Mar 4, 2026EXHIBITPATENT OWNER

Han, Aslanian, & Yates, “Mass spectrometry for proteomics,”

Mar 4, 2026EXHIBITPATENT OWNER

May & McLean, “Advanced Multidimensional Separations in Mass Spectrometry: Navigating the Big Data Deluge,”

Mar 4, 2026EXHIBITPATENT OWNER

Wright & Wright, “Advances in LC: Bioanalytical Method Transfer,”

Mar 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 78

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 59

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 68

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 28

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 35

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 37

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 45

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 67

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 83

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 87

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 91

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 92

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 99

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 102

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 110

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) D.I. 76

Feb 4, 2026EXHIBITPATENT OWNER

Genzyme Corporation v. Sarepta Therapeutics Inc. (1:24-cv-00882) - Defendant’s Supplemental Initial Invalidity Contentions

Feb 4, 2026EXHIBITPATENT OWNER

Vliet

Feb 4, 2026EXHIBITPATENT OWNER

Bark

Feb 4, 2026EXHIBITPATENT OWNER

Patent Owner's Request for Discretionary Denial

Feb 4, 2026PAPERPATENT OWNER

Patent Owner's Mandatory Notices

Jan 20, 2026PAPERPATENT OWNER

Petitioner's Sotera Stipulation

Dec 30, 2025PAPERPETITIONER

Notice of Intent to Designate Katherine Helm as Back-Up Counsel

Dec 29, 2025PAPERPATENT OWNER

Declaration of Katherine Helm

Dec 29, 2025EXHIBITPATENT OWNER

Notice: Power of Attorney

Dec 23, 2025PAPERPATENT OWNER

Notice: Mandatory Notice

Dec 23, 2025PAPERPATENT OWNER

Notice: Notice filing date accorded

Dec 4, 2025PAPERBOARD

Ex. 1001

Dec 2, 2025EXHIBITPETITIONER

Ex. 1002 Part 1

Dec 2, 2025EXHIBITPETITIONER

Ex. 1002 Part 2

Dec 2, 2025EXHIBITPETITIONER

Ex. 1002 Part 3

Dec 2, 2025EXHIBITPETITIONER

Ex. 1002 Part 4

Dec 2, 2025EXHIBITPETITIONER

Ex. 1002 Part 5

Dec 2, 2025EXHIBITPETITIONER

Ex. 1004

Dec 2, 2025EXHIBITPETITIONER

Ex. 1005

Dec 2, 2025EXHIBITPETITIONER

Ex. 1006

Dec 2, 2025EXHIBITPETITIONER

Ex. 1007

Dec 2, 2025EXHIBITPETITIONER

Ex. 1008

Dec 2, 2025EXHIBITPETITIONER

Ex. 1009

Dec 2, 2025EXHIBITPETITIONER

Ex. 1010

Dec 2, 2025EXHIBITPETITIONER

Ex. 1011

Dec 2, 2025EXHIBITPETITIONER

Ex. 1012

Dec 2, 2025EXHIBITPETITIONER

Ex. 1013

Dec 2, 2025EXHIBITPETITIONER

Ex. 1014

Dec 2, 2025EXHIBITPETITIONER

Ex. 1015

Dec 2, 2025EXHIBITPETITIONER

Ex. 1016

Dec 2, 2025EXHIBITPETITIONER

Ex. 1017

Dec 2, 2025EXHIBITPETITIONER

Ex. 1018

Dec 2, 2025EXHIBITPETITIONER

Ex. 1019

Dec 2, 2025EXHIBITPETITIONER

Ex. 1020

Dec 2, 2025EXHIBITPETITIONER

Ex. 1021

Dec 2, 2025EXHIBITPETITIONER

Ex. 1022

Dec 2, 2025EXHIBITPETITIONER

Ex. 1023

Dec 2, 2025EXHIBITPETITIONER

Ex. 1024

Dec 2, 2025EXHIBITPETITIONER

Ex. 1025

Dec 2, 2025EXHIBITPETITIONER

Ex. 1026

Dec 2, 2025EXHIBITPETITIONER

Ex. 1027

Dec 2, 2025EXHIBITPETITIONER

Ex. 1028

Dec 2, 2025EXHIBITPETITIONER

Ex. 1029

Dec 2, 2025EXHIBITPETITIONER

Ex. 1030

Dec 2, 2025EXHIBITPETITIONER

Ex. 1031

Dec 2, 2025EXHIBITPETITIONER

Ex. 1032

Dec 2, 2025EXHIBITPETITIONER

Ex. 1033

Dec 2, 2025EXHIBITPETITIONER

Ex. 1034

Dec 2, 2025EXHIBITPETITIONER

Ex. 1035

Dec 2, 2025EXHIBITPETITIONER

Ex. 1036

Dec 2, 2025EXHIBITPETITIONER

Ex. 1037

Dec 2, 2025EXHIBITPETITIONER

Ex. 1038

Dec 2, 2025EXHIBITPETITIONER

Ex. 1039

Dec 2, 2025EXHIBITPETITIONER

Ex. 1040

Dec 2, 2025EXHIBITPETITIONER

Notice: Power of Attorney

Dec 2, 2025PAPERPETITIONER

Ex. 1003

Dec 2, 2025EXHIBITPETITIONER

Petition: as filed

Dec 2, 2025PAPERPETITIONER